Comparative Benchmarking
In the context of the broader market, PRQR competes directly with industry leaders such as TNYA and TKNO. With a market capitalization of $170.68M, it holds a leading position in the sector. When comparing efficiency, PRQR's gross margin of N/A stands against TNYA's N/A and TKNO's 29.62%. Such benchmarking helps identify whether ProQR Therapeutics NV is trading at a premium or discount relative to its financial performance.
